eprintid: 21505
rev_number: 12
eprint_status: archive
userid: 1589
dir: disk0/00/02/15/05
datestamp: 2016-07-20 11:18:32
lastmod: 2024-08-01 21:09:04
status_changed: 2016-07-20 11:18:32
type: article
metadata_visibility: show
creators_name: Chalmers, Don
creators_name: Nicol, Dianne
creators_name: Kaye, Jane
creators_name: Bell, Jessica
creators_name: Campbell, Alastair V.
creators_name: Ho, Calvin W. L.
creators_name: Kato, Kazuto
creators_name: Minari, Jusaku
creators_name: Ho, Chih-hsing
creators_name: Mitchell, Colin
creators_name: Molnár-Gábor, Fruzsina
creators_name: Otlowski, Margaret
creators_name: Thiel, Daniel
creators_name: Fullerton, Stephanie M.
creators_name: Whitton, Tess
title: Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era
subjects: ddc-000
subjects: ddc-610
divisions: i-850500
abstract: Biobanks have been heralded as essential tools for translating biomedical research into practice, driving precision medicine to improve pathways for global healthcare treatment and services. Many nations have established specific governance systems to facilitate research and to address the complex ethical, legal and social challenges that they present, but this has not lead to uniformity across the world. Despite significant progress in responding to the ethical, legal and social implications of biobanking, operational, sustainability and funding challenges continue to emerge. No coherent strategy has yet been identified for addressing them. This has brought into question the overall viability and usefulness of biobanks in light of the significant resources required to keep them running. This review sets out the challenges that the biobanking community has had to overcome since their inception in the early 2000s. The first section provides a brief outline of the diversity in biobank and regulatory architecture in seven countries: Australia, Germany, Japan, Singapore, Taiwan, the UK, and the USA. The article then discusses four waves of responses to biobanking challenges. This article had its genesis in a discussion on biobanks during the Centre for Health, Law and Emerging Technologies (HeLEX) conference in Oxford UK, co-sponsored by the Centre for Law and Genetics (University of Tasmania). This article aims to provide a review of the issues associated with biobank practices and governance, with a view to informing the future course of both large-scale and smaller scale biobanks.
date: 2016
publisher: BioMed Central
id_scheme: DOI
ppn_swb: 165786829X
own_urn: urn:nbn:de:bsz:16-heidok-215053
language: eng
bibsort: CHALMERSDOHASTHEBIOB2016
full_text_status: public
publication: BMC Medical Ethics
volume: 17
number: 39
place_of_pub: London
pagerange: 1-14
issn: 1472-6939
citation:   Chalmers, Don ; Nicol, Dianne ; Kaye, Jane ; Bell, Jessica ; Campbell, Alastair V. ; Ho, Calvin W. L. ; Kato, Kazuto ; Minari, Jusaku ; Ho, Chih-hsing ; Mitchell, Colin ; Molnár-Gábor, Fruzsina ; Otlowski, Margaret ; Thiel, Daniel ; Fullerton, Stephanie M. ; Whitton, Tess  (2016) Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era.  BMC Medical Ethics, 17 (39).  pp. 1-14.  ISSN 1472-6939     
document_url: https://archiv.ub.uni-heidelberg.de/volltextserver/21505/1/12910_2016_Article_124.pdf